Thiamine deficiency in a patient receiving chemotherapy for acute myeloblastic leukemia

Acute acalculous cholecystitis complicating chemotherapy for acute myeloblastic leukemia

Acute acalculous cholecystitis is a rare complication in the treatment of acute myeloblastic leukemia. Diagnosis of acute acalculous cholecystitis remains difficult during neutropenic period. We present two acute myeloblastic leukemia patients that developed acute acalculous cholecystitis during chemotherapy-induced neutropenia. They suffered from fever, vomiting and acute pain in the epigastri...

Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.

Prophylactic platelet transfusion reduces the risk of hemorrhage in patients undergoing chemotherapy for leukemia, and platelet transfusions have been given when the platelet count falls below 20,000/μL (1). Recently, several clinical trials have demonstrated that for prophylactic platelet transfusions, the platelet trigger value of 10,000/μL is superior to that of 20,000/μL in terms of safety ...

Occurrence of Secondary Acute Myeloid Leukemia in a Patient with Breast Cancer after Chemotherapy

Central Hypothyroidism: A Rare Complication in a Child Undergoing Chemotherapy for Acute Lymphoblastic Leukemia

Abnormalities of the thyroid gland are among the most frequent endocrine complications observed in childhood cancer survivors. We report an 11 years old girl who developed central hypothyroidism and ACTH deficiency during the chemotherapy for CNS relapse of acute lymphoblastic leukemia before receiving radiotherapy. Keywords: Thyroid gland, hypothyroidism, chemotherapy, acute lymphoblastic leu...

Diagnosis of Large Granular Lymphocytic Leukemia in a Patient Previously Treated for Acute Myeloblastic Leukemia

Large granular lymphocytic (LGL) leukemia is a lymphoproliferative disease characterized by the clonal expansion of cytotoxic T or natural killer cells. We report on a patient diagnosed with T-cell LGL leukemia two years after the achievement of hematologic remission for acute myeloblastic leukemia.